SLEB5
MCID: SYS053
MIFTS: 16

Systemic Lupus Erythematosus 5 (SLEB5)

Categories: Bone diseases, Genetic diseases, Immune diseases, Nephrological diseases, Rare diseases, Skin diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Systemic Lupus Erythematosus 5

MalaCards integrated aliases for Systemic Lupus Erythematosus 5:

Name: Systemic Lupus Erythematosus 5 57
Systemic Lupus Erythematosus, Susceptibility to, 5 57 12
Sleb5 57

Classifications:



External Ids:

OMIM® 57 609903
MedGen 40 C1835929

Summaries for Systemic Lupus Erythematosus 5

MalaCards based summary: Systemic Lupus Erythematosus 5, also known as systemic lupus erythematosus, susceptibility to, 5, is related to systemic lupus erythematosus and systemic lupus erythematosus 1. An important gene associated with Systemic Lupus Erythematosus 5 is SLEB5 (Systemic Lupus Erythematosus, Susceptibility To, 5). Affiliated tissues include b cells and kidney.

More information from OMIM: 609903

Related Diseases for Systemic Lupus Erythematosus 5

Graphical network of the top 20 diseases related to Systemic Lupus Erythematosus 5:



Diseases related to Systemic Lupus Erythematosus 5

Symptoms & Phenotypes for Systemic Lupus Erythematosus 5

Clinical features from OMIM®:

609903 (Updated 24-Oct-2022)

Drugs & Therapeutics for Systemic Lupus Erythematosus 5

Search Clinical Trials, NIH Clinical Center for Systemic Lupus Erythematosus 5

Genetic Tests for Systemic Lupus Erythematosus 5

Anatomical Context for Systemic Lupus Erythematosus 5

Organs/tissues related to Systemic Lupus Erythematosus 5:

MalaCards : B Cells, Kidney

Publications for Systemic Lupus Erythematosus 5

Articles related to Systemic Lupus Erythematosus 5:

(show all 25)
# Title Authors PMID Year
1
Genetic linkage of systemic lupus erythematosus to 13q32 in African American families with affected male members. 57
16189706 2005
2
Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review. 62
34872742 2022
3
Lymphocytic interstitial pneumonia: computed tomography findings in 36 patients. 62
33071371 2020
4
Bradycardia caused by interaction of venlafaxine and cyclosporine: A case report. 62
31814947 2019
5
Development of systemic lupus erythematosus 5 years after onset of thrombotic thrombocytopenic purpura. 62
28707764 2017
6
Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population survey. 62
28931060 2017
7
Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing. 62
25834211 2015
8
Effects of different trends on the development and outcome of early kidney allograft dysfunction. 62
25894160 2015
9
Effects of exercise on depression in adults with arthritis: a systematic review with meta-analysis of randomized controlled trials. 62
25645739 2015
10
Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients. 62
20188618 2010
11
Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy. 62
20025587 2009
12
Characterization of a susceptibility locus for SLE, SLEB5, on chromosome 4p14-13. 62
16918700 2006
13
Clinical and laboratory manifestations of Kikuchi's disease in children and differences between patients with and without prolonged fever. 62
15933568 2005
14
Kikuchi's disease in Asian children. 62
15629971 2005
15
Apparent diffusion coefficient mapping of the normal parotid gland and parotid involvement in patients with systemic connective tissue disorders. 62
14729521 2004
16
Comparing peritonitis in continuous ambulatory peritoneal dialysis patients versus automated peritoneal dialysis patients. 62
10682100 1999
17
[A comparative evaluation of the efficacy of peroral and intravenous pulse therapy with methylprednisolone in rheumatic diseases]. 62
10050456 1998
18
[Bromocriptine for refractory rheumatoid arthritis]. 62
9451892 1997
19
Reliability and validity of a submaximal treadmill test to estimate aerobic capacity in women with rheumatic disease. 62
8877918 1996
20
A prospective analysis of patients with rheumatic diseases attending referral hospitals in Harare, Zimbabwe. 62
1795322 1991
21
Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course. 62
1956482 1991
22
[A study of microproteinuria in patients with collagen disease]. 62
2593319 1989
23
[Systemic lupus erythematosus 5 years after thymectomy for myasthenia gravis]. 62
3162070 1985
24
[Inferior caval syndromes. Apropos of 45 cases]. 62
6320431 1984
25
Relationship between reduced B cell susceptibility to IgM antibodies and reduced IgD-bearing B cells in patients with systemic lupus erythematosus. 62
6983356 1982

Variations for Systemic Lupus Erythematosus 5

Expression for Systemic Lupus Erythematosus 5

Search GEO for disease gene expression data for Systemic Lupus Erythematosus 5.

Pathways for Systemic Lupus Erythematosus 5

GO Terms for Systemic Lupus Erythematosus 5

Sources for Systemic Lupus Erythematosus 5

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 24-Oct-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....